PRISM BioLab Co.,LTD
PRISM BioLab Co.,LTD scores highest on Torque (53) and lowest on Price (13). Its PosiPenta is 23.97 out of 100, weaker than most similar companies.
On the Penta Grid this week, PRISM BioLab Co.,LTD is Grid #49 of 49 in the Healthcare sector in Japan, and Grid #974 of 986 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| PRISM BioLab Co.,LTD | 23.97 | 13 | 16 | 17 | 53 | 21 |
| Hi-CRATES CO.,LTD. | 68.48 | 80 | 55 | 65 | 83 | 60 |
| Nippon Chemiphar Co., Ltd. | 36.69 | 50 | 13 | 41 | 22 | 58 |
| SUSMED,Inc. | 33.21 | 28 | 50 | 3 | 57 | 29 |
| AIAI Group Corporation | 49.19 | 82 | 63 | 15 | 46 | 40 |
| Kohjin Bio Co., Ltd. | 34.55 | 54 | 39 | 9 | 36 | 36 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.62 |
| P/B ratio | 2.64 |
EEarnings
| Trailing EPS | ₹-14.54 |
| Forward EPS | — |
NNitro
| Price | 81.72 |
| 52-week high | 168.90 |
| 52-week low | 75.67 |
| Fall from 52-week high | 51.6% |
TTorque
| Return on equity (ROE) | -37.89% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.40 |
| Market cap | ₹302 Cr |
| Insider holding | 36.07% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is PRISM BioLab Co.,LTD's PosiPenta score?
PRISM BioLab Co.,LTD's PosiPenta is 23.97 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does PRISM BioLab Co.,LTD stand on the Penta Grid?
On the Penta Grid this week, PRISM BioLab Co.,LTD is Grid #49 of 49 in the Healthcare sector in Japan, and Grid #974 of 986 in Japan.
Which PosiPenta pillar is strongest for PRISM BioLab Co.,LTD?
Torque (durability), with a score of 53 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for PRISM BioLab Co.,LTD?
Price (valuation), with a score of 13 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.